Lukas Flatz (L Flatz)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Topics

Clostridium Difficile

Lipopolysaccharide Induced

Mild Cognitive Impairment

Top Venues

Acta neuropathologica communications

Cancer immunology, immunotherapy : CII

American journal of respiratory and critical care medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Lukas Flatz, Nikolaus B Wagner, Natalja Denisjuk, Peter Do, Lisa Nadal, Emanuele Puca, Giuliano Elia, Alfredo Covelli, Dario Neri, Antonio Cozzio
Intratumoral administration of daromun in non-melanoma skin cancer: Preliminary results from a phase 2 non-randomized controlled trial. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Nathalie A Lengacher, Julianna J Tomlinson, Ann-Kristin Jochum, Jonas Franz, Omar Hasan Ali, Lukas Flatz, Wolfram Jochum, Wolfram Jochum, null null, Christine Stadelmann, John M Woulfe, Michael G Schlossmacher
Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19. Acta neuropathologica communications 12 (1) (2024)
Nathalie A Lengacher, Julianna J Tomlinson, Ann-Kristin Jochum, Jonas Franz, Omar Hasan Ali, Lukas Flatz, Wolfram Jochum, Wolfram Jochum, null null, Christine Stadelmann, John M Woulfe, Michael G Schlossmacher
Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19. Acta neuropathologica communications 12 (1) (2024)
Nathalie A Lengacher, Julianna J Tomlinson, Ann-Kristin Jochum, Jonas Franz, Omar Hasan Ali, Lukas Flatz, Wolfram Jochum, Wolfram Jochum, null null, Christine Stadelmann, John M Woulfe, Michael G Schlossmacher
Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19. Acta neuropathologica communications 12 (1) (2024)
A Gawaz, I Wolff, L Nanz, Lukas Flatz, Andrea Forschner
Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients ≥ 75 years: results of a real-world cohort including 456 patients. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Nina Wyss, Fiamma Berner, Vincent Walter, Ann-Kristin Jochum, Mette T Purde, Marie-Therese Abdou, Tobias Sinnberg, Kathrin Hofmeister, Oltin T Pop, Omar Hasan Ali, Jens Bauer, Hung-Wei Cheng, Mechthild Lütge, Niklas Klümper, Stefan Diem, Zeynep Kosaloglu-Yalcin, Yizheng Zhang, Laura Sellmer, Boris Macek, Julia Karbach, David König, Heinz Läubli, Lars Zender, Britta S Meyer, Christoph Driessen, Christian M Schürch, Wolfram Jochum, Teresa Amaral, Lucie Heinzerling, Antonio Cozzio, Ahmed N Hegazy, Tino Schneider, Martin H Brutsche, Alessandro Sette, Tobias L Lenz, Juliane Walz, Hans-Georg Rammensee, Martin Früh, Elke Jäger, Burkhard Becher, Amanda Tufman, Nicolas Nuñez, Markus Joerger, Lukas Flatz
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade. American journal of respiratory and critical care medicine (2024)
Nathalie A Lengacher, Julianna J Tomlinson, Ann-Kristin Jochum, Jonas Franz, Omar Hasan Ali, Lukas Flatz, Wolfram Jochum, Wolfram Jochum, null null, Christine Stadelmann, John M Woulfe, Michael G Schlossmacher
Correction: Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19. Acta neuropathologica communications 12 (1) (2024)
A Gawaz, I Wolff, L Nanz, Lukas Flatz, Andrea Forschner
Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients ≥ 75 years: results of a real-world cohort including 456 patients. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Nathalie A Lengacher, Julianna J Tomlinson, Ann-Kristin Jochum, Jonas Franz, Omar Hasan Ali, Lukas Flatz, Wolfram Jochum, Wolfram Jochum, null null, Christine Stadelmann, John M Woulfe, Michael G Schlossmacher
Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19. Acta neuropathologica communications 12 (1) (2024)
A Gawaz, I Wolff, L Nanz, Lukas Flatz, Andrea Forschner
Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients ≥ 75 years: results of a real-world cohort including 456 patients. Cancer immunology, immunotherapy : CII 73 (9) (2024)
T Grünke, S Reiter, S Meyer, J Graf, N Schaeffeler, Ulrike Leiter, Teresa Amaral, Lukas Flatz, A Forschner
Exploring 'decision regret' in adjuvant-treated melanoma patients: Results from a cross-sectional survey on 200 participants. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
A Gawaz, I Wolff, L Nanz, Lukas Flatz, Andrea Forschner
Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients ≥ 75 years: results of a real-world cohort including 456 patients. Cancer immunology, immunotherapy : CII 73 (9) (2024)
Nina Wyss, Fiamma Berner, Vincent Walter, Ann-Kristin Jochum, Mette T Purde, Marie-Therese Abdou, Tobias Sinnberg, Kathrin Hofmeister, Oltin T Pop, Omar Hasan Ali, Jens Bauer, Hung-Wei Cheng, Mechthild Lütge, Niklas Klümper, Stefan Diem, Zeynep Kosaloglu-Yalcin, Yizheng Zhang, Laura Sellmer, Boris Macek, Julia Karbach, David König, Heinz Läubli, Lars Zender, Britta S Meyer, Christoph Driessen, Christian M Schürch, Wolfram Jochum, Teresa Amaral, Lucie Heinzerling, Antonio Cozzio, Ahmed N Hegazy, Tino Schneider, Martin H Brutsche, Alessandro Sette, Tobias L Lenz, Juliane Walz, Hans-Georg Rammensee, Martin Früh, Elke Jäger, Burkhard Becher, Amanda Tufman, Nicolas Nuñez, Markus Joerger, Lukas Flatz
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade. American journal of respiratory and critical care medicine (2024)
Fiamma Berner, Lukas Flatz
Autoimmunity in immune checkpoint inhibitor-induced immune-related adverse events: A focus on autoimmune skin toxicity and pneumonitis. Immunological reviews (2023)
Tobias Sinnberg, Christa Lichtensteiger, Omar Hasan Ali, Oltin T Pop, Ann-Kristin Jochum, Lorenz Risch, Silvio D Brugger, Ana Velic, David Bomze, Philipp Kohler, Pietro Vernazza, Werner C Albrich, Christian R Kahlert, Maire-Therese Abdou, Nina Wyss, Kathrin Hofmeister, Heike Niessner, Carl Zinner, Mara Gilardi, Alexandar Tzankov, Martin Röcken, Alex Dulovic, Srikanth Mairpady Shambat, Natalia Ruetalo, Philipp K Buehler, Thomas C Scheier, Wolfram Jochum, Lukas Kern, Samuel Henz, Tino Schneider, Gabriela M Kuster, Maurin Lampart, Martin Siegemund, Roland Bingisser, Michael Schindler, Nicole Schneiderhan-Marra, Hubert Kalbacher, Kathy D McCoy, Werner Spengler, Martin H Brutsche, Boris Macek, Raphael Twerenbold, Josef M Penninger, Matthias S Matter, Lukas Flatz
Pulmonary Surfactant Proteins are Inhibited by IgA Autoantibodies in Severe COVID-19. American journal of respiratory and critical care medicine (2022)
Fiamma Berner, David Bomze, Christa Lichtensteiger, Vincent Walter, Rebekka Niederer, Omar Hasan Ali, Nina Wyss, Jens Bauer, Lena Katharina Freudenmann, Ana Marcu, Eva-Maria Wolfschmitt, Sebastian Haen, Thorben Gross, Marie-Therese Abdou, Stefan Diem, Stella Knöpfli, Tobias Sinnberg, Kathrin Hofmeister, Hung-Wei Cheng, Marieta Toma, Niklas Klümper, Mette-Triin Purde, Oltin Tiberiu Pop, Ann-Kristin Jochum, Steve Pascolo, Markus Joerger, Martin Früh, Wolfram Jochum, Hans-Georg Rammensee, Heinz Laubli, Michael Hudecek, Jacques J C Neefjes, Juliane Sarah Walz, Lukas Flatz
Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade. Science immunology 7 (75) (2022)
Fiamma Berner, Rebekka Niederer, Jolien J Luimstra, Oltin Tiberiu Pop, Ann-Kristin Jochum, Mette-Triin Purde, Omar Hasan Ali, David Bomze, Jens Bauer, Lena Katharina Freudenmann, Ana Marcu, Eva-Maria Wolfschmitt, Sebastian Haen, Thorben Gross, Marissa Lisa Dubbelaar, Marie-Therese Abdou, Petra Baumgaertner, Christina Appenzeller, Caroline Cicin-Sain, Tobias Lenz, Daniel E Speiser, Burkhard Ludewig, Christoph Driessen, Markus Jörger, Martin Früh, Wolfram Jochum, Antonio Cozzio, Hans-Georg Rammensee, Juliane Walz, Jacques Neefjes, Lukas Flatz
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival. Oncoimmunology 10 (1) (2021)
Mette-Triin Purde, Rebekka Niederer, Nikolaus B Wagner, Stefan Diem, Fiamma Berner, Omar Hasan Ali, Dorothea Hillmann, Irina Bergamin, Markus Joerger, Martin Risch, Christoph Niederhauser, Tobias L Lenz, Martin Früh, Lorenz Risch, David Semela, Lukas Flatz
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients. Journal of cancer research and clinical oncology (2021)
Maximilian Boesch, Florent Baty, Werner C Albrich, Lukas Flatz, Regulo Rodriguez, Sacha I Rothschild, Markus Joerger, Martin Früh, Martin Hugo Brutsche
Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer. Oncoimmunology 10 (1) (2021)
Willem van de Veen, Anna Globinska, Kirstin Jansen, Alex Straumann, Terufumi Kubo, Daniëlle Verschoor, Oliver Fabian Wirz, Francesc Castro Giner, Ge Tan, Beate Rückert, Urs Ochsner, Marietta Herrmann, Barbara Stanić, Marloes van Splunter, Daan W Huntjens, Alexandra Wallimann, Rodney J Fonseca Guevara, Hergen Spits, Desislava Ignatova, Yun-Tsan Chang, Christina Fassnacht, Emmanuella Guenova, Lukas Flatz, Mübeccel Akdis, Mübeccel Akdiş
A novel proangiogenic B cell subset is increased in cancer and chronic inflammation. Science advances 6 (20) (2020)